Pre-made Besilesomab benchmark antibody (Radiolabelled antibody, anti-CEACAM8/NCA-95 therapeutic antibody, Anti-CD66b/CD67/CGM6 Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-INN-756

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-INN-756 Category Tag

Product Details

Pre-made Besilesomab benchmark antibody (Radiolabelled antibody, anti-CEACAM8/NCA-95 therapeutic antibody, Anti-CD66b/CD67/CGM6 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Besilesomab?(trade name?Scintimun) is a?mouse?monoclonal antibody?labelled with the radioactive isotope?technetium-99m. It is used to detect inflammatory lesions and?metastases.[1]?It binds to an?immunoglobulin, IgG1?isotype. SCINTIMUN has been used since 1992 mainly in Hungary, Czech Republic, and Switzerland on the basis of local marketing authorizations, and in Germany (on the basis of individual prescription). Between 1992 and 2009, an estimated 90,000 patients has been studied. In 2009, the?EMEA?has approved SCINTIMUN for marketing in all European countries.[

Products Name (INN Index)

Pre-Made Besilesomab Biosimilar, Radiolabelled Antibody, Anti-Ceacam8/NCA-95 Antibody: Anti-CD66b/CD67/CGM6 therapeutic antibody

INN Name

besilesomab

Target

CEACAM8

Format

Radiolabelled antibody

Derivation

Mus musculus

Species Reactivity

Human

CH1 Isotype

IgG1 – kappa

VD LC

IgG1 – kappa

Highest_Clin_Trial (Jan '20)

NA

Est. Status

NA

100% SI Structure

NA

99% SI Structure

NA

95-98% SI Structure

NA

Year Proposed

NA

Companies

Iba?Molecular Imaging (Louvain- la-Neuve Belgium)

Conditions Approved

NA

Conditions Active

NA

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

CEACAM8

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide